San Antonio Eye Center

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Macular degeneration5 trials
• Diabetic eye disease1 trial

Phase

• Phase 22 trials
• Phase 32 trials

Status

• Active, not recruiting3 trials
• Completed3 trials

Lead sponsor

• EyePoint Pharmaceuticals, Inc.2 trials
• Complement Therapeutics1 trial
• Genentech, Inc.1 trial
• Janssen Research & Development, LLC1 trial
• Smilebiotek Zhuhai Limited1 trial

Running trials

• Active, not recruiting

  CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME

  NCT07449923· Phase 3· EyePoint Pharmaceuticals, Inc.· Source

• Active, not recruiting

  A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUGANO) Primary Efficacy Will be Determined at Week 56

  NCT06668064· Phase 3· EyePoint Pharmaceuticals, Inc.· Source

• Active, not recruiting

  An Observational Study of the Progression of Intermediate Age-Related Macular Degeneration

  NCT05300724· Genentech, Inc.· Source

Closed trials

• Completed

  A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  NCT05811351· Phase 2· Janssen Research & Development, LLC· Source

• Completed

  Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study

  NCT05797896· Complement Therapeutics· Source

• Completed

  QA102 Phase II Study in Subjects With Dry AMD

  NCT05536752· Phase 2· Smilebiotek Zhuhai Limited· Source